Spectralis OCT’s Progression Analysis
Several commercially available spectral domain-OCT devices can provide the clinician with an assessment of course of glaucoma. There is no clear evidence showing superiority of any one device for this task. Although many of the approaches used for calculation of structural parameters are similar among many devices, each manufacturer has taken somewhat different approaches to assist with detecting glaucomatous damage and diagnosing progression. Spectralis OCT (Heidelberg Engineering Inc., Heidelberg, Germany) provides event-based and trend-based analyses for detection of glaucoma progression. In addition to the retinal nerve fiber layer, the optic nerve head and posterior pole outcomes can be utilized for monitoring of the disease with Spectralis OCT.
KeywordsGlaucoma progression OCT progression Spectralis OCT progression analysis